Sigma Biotech Consulting Group Launches to Accelerate Biotech and Medical Device Innovation

Integrated consulting approach streamlines pathway from concept to commercialization

NEW YORK, NY, UNITED STATES, April 7, 2026 /EINPresswire.com/ -- Sigma Biotech Consulting, a New York City–based biotech consulting firm, today announced its official launch, offering an integrated approach to help medical device and biotech companies efficiently advance products from concept through commercialization.

Founded by Principal Strategic Consultant Rachel Hoffman, Sigma addresses a critical industry challenge: fragmented development processes that slow progress and increase costs. By aligning scientific evidence, clinical planning, regulatory strategy, and commercial positioning, the firm helps clients reduce surprises or delays in development to bring innovations to market faster.

“Too often, development and approval efforts operate in silos, leading to inefficiencies and extended timelines,” said Hoffman. “Our mission is to elevate biotech consulting by combining scientific depth with business clarity. We ensure every deliverable—from clinical strategy to regulatory submissions to market adoption—is aligned, intentional, and designed to move programs forward.”

The Sigma team supports early-stage companies seeking to bring new products to market, as well as organizations facing development or regulatory delays. The firm specializes in Class II and Class III medical devices and diagnostics, with deep expertise in hemostats, advanced biomaterials, and spinal instrumentation.

A key differentiator is Sigma’s cohesive team, whose members have worked together extensively and bring a shared, execution-focused approach. This enables the firm to anticipate challenges, identify efficiencies, and guide clients through complex clinical and regulatory pathways with greater speed and precision.

“At a time when capital efficiency and speed to market are more important than ever, companies need partners who can see the full picture,” says Dr. William Spotnitz, Chief Medical Officer. “We help clients navigate complexity with confidence—so they can focus on delivering meaningful innovations to patients.”

Sigma is now accepting new clients. For more information or to schedule a consultation, visit https://sigmabioconsulting.com.

About Sigma Biotech Consulting Group
Sigma Bio is a New York City–based biotech consulting firm, with a global expertise specializing in scientific evidence generation, regulatory strategy, clinical development, and commercial planning for medical device and biotechnology companies. By integrating technical expertise with strategic insight, Sigma helps clients efficiently advance products from concept to commercialization. The firm is a minority female-owned business committed to delivering high-impact, results-driven solutions.

Jeffrey M. Hoffman
Sigma Biotech Consulting Group
+1 404-431-4676
email us here
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.